INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
49 hedge funds and large institutions have $183M invested in Inozyme Pharma in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
49
Holders Change
+12
Holders Change %
+32.43%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
17
Increased
18
Reduced
5
Closed
5
Calls
$166K
Puts
$378K
Net Calls
-$212K
Net Calls Change
-$212K
Top Buyers
Top Sellers
| 1 |
CA
1
CHI Advisors
New York
|
$7.69M |
| 2 |
VA
2
VR Adviser
New York
|
$0 |
| 3 |
3
Renaissance Technologies
New York
|
$1.07M |
| 4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$673K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$7.61M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | – | -37,700 | Closed |
|
52
Goldman Sachs
New York
| – | – | -11,924 | Closed |
|
53
UBS Group
Zurich,
Switzerland
| – | – | -2,834 | Closed |
|
54
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -1,381 | Closed |
|
|
CFGS
55
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
56
JPMorgan Chase & Co
New York
| $0 | 60 | – | – |
|
57
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|